anavex.com (AVXL) - Uzoq muddatli majburiyatlarning kapitalga nisbati
Anavex Life Sciences (AVXL) G'arb bozorlarida minimal siyosiy xavf va savdo barqarorligi sharoitlarida faoliyat yuritmoqda. Kompaniya Parkinson va Altsgeymer kasalliklarida neyronlarni tiklashning innovatsion vositalarini ishlab chiqmoqda va global yetakchilikni maqsad qilgan. Ko'rsatkich 0.00 darajasida bo'lgan aksiya narxi tendentsiyasi shunday rivojlanish bosqichini aks ettiradiki, u patentlash muvaffaqiyatli yakunlangach, dori vositalarining arzon ishlab chiqarilishi hisobiga ulkan foydalarni ta'minlaydi.
&width=1200&height=400&colorIndex=0&v=mvvwvvs9.gq-7b28iyo&start=20220704&end=20261031&filename=GURU_Markets_-_AVXL_-_Anavex-Life-Sciences_-_Long-Term-Debt-to-Equity-Ratio "AVXL - Anavex Life Sciences Corp. Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 31.10.2026 oraligʻida | 👁️GURU.Markets👁️")
Anavex Life Sciences (AVXL) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi ko'rsatkichlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati Anavex Life Sciences|AVXL - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati anavex.com|AVXL - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Anavex Life Sciences Corp.|AVXL - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzlari Anavex Life Sciences|Tezkor likvidlik anavex.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning har tomonlama tahlili:Anavex AVXL
Professional investorlar emitentning moliyaviy barqarorligini uzoq muddatli qarzdorlikning kapitalga nisbati orqali baholaydilar, bu esa biznesning tashqi qarzga bog'liqlik darajasini aniqlash imkonini beradi. Joriy uzoq muddatli qarzdorlikning kapitalga nisbatini tahlil qilish orqali, Anavex Life Sciences (AVXL) bankrotlik xavfisiz shifokorlar ishtirokidagi qimmatbaho klinik sinovlarni moliyalashtirish uchun yetarli resurslarga ega yoki yo'qligini aniqlash va shu tariqa aktivning umumiy ishonchliligini tasdiqlash mumkin.
Muhim raqobatchilar
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BIIB (Biogen Inc)|Uzoq muddatli qarzning kapitalga nisbati NBIX|RGC - Uzoq muddatli majburiyatlarning kapitalga nisbati|Axsome Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati acadia-pharm.com ACAD|XENE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti VKTX (Viking Therapeutics Inc)|Supernus Pharma (SUPN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Catalyst Corp (CPRX)|DNLI (Denali Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati harmonybiosciences.com|Uzoq muddatli qarzning o'z kapitaliga nisbati Biohaven (BHVN)|Amylyx Pharmaceuticals Inc - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati TRVI (Trevi Pharma)|Uzoq muddatli qarzning kapitalga nisbati Praxis Corp PRAX|CBLL: Uzoq muddatli qarzning o'z kapitaliga nisbati|PRTA: Uzoq muddatli qarzning o'z kapitaliga nisbati|ALEC: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Annexon Biosciences (ANNX)|Uzoq muddatli qarzning o'z kapitaliga nisbati OMER|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi NGNE (Neurogene Therapeutics)|Uzoq muddatli qarzning o'z kapitaliga nisbati ACIU (AC Immune)|VYGR (voyagertherapeutics.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Neumora Therapeutics, Inc. NMRA|Scilex Holding - Uzoq muddatli qarzning o'z kapitaliga nisbati|Tevogen Bio Holdings, Inc. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Alpha Cognition ACOG|CGTX: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati IKT (inhibikase.com)|SAVA (Cassava Sciences) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Assertio Therapeutics ASRT|Uzoq muddatli qarzning o'z kapitaliga nisbati COYA (Coya Therapeutics, Inc.)|VTGN (vistagen.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Ovid Therapeutics OVID|Uzoq muddatli qarzdorlikning kapitalga nisbati acumenpharm.com (ABOS)|CervoMed - Uzoq muddatli qarzning kapitalga nisbati|Alterity Therapeutics (ATHE) - Uzoq muddatli qarzning o'z kapitaliga nisbati|CLNN: Uzoq muddatli qarzning kapitalga nisbati|PEPG - Uzoq muddatli qarzdorlikning kapitalga nisbati|JUNS (Jupiter Neurosciences Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati relmada.com RLMD|Uzoq muddatli qarzning o'z kapitaliga nisbati Annovis Bio (ANVS)|gracetx.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati AIFF (Firefly Neuroscience Inc)|KLTO - Uzoq muddatli qarzning o'z kapitaliga nisbati|NeuroSense Therapeutics, Ltd. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati revivapharma.com|metaviatx.com (MTVA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|NRXS - Uzoq muddatli qarzdorlikning kapitalga nisbati|HSDT (Helius Medical Technologies, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati Passage Bio Corp|Uzoq muddatli qarzning o'z kapitaliga nisbati NEUP (Neuphoria Therapeutics Inc.)|Uzoq muddatli qarzning o'z kapitaliga nisbati NERV (minervaneurosciences.com)|Athira Pharma - Uzoq muddatli qarzning o'z kapitaliga nisbati|ADXN: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|ALZN - Uzoq muddatli qarzning o'z kapitaliga nisbati|CYCN: Uzoq muddatli qarzning o'z kapitaliga nisbati|protagenic.com (PTIX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi KTTA|CRGT (Cortigent Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Avenue Therapeutics Inc. ATXI|Uzoq muddatli qarzning o'z kapitaliga nisbati BCLI (Brainstorm Cell Therapeutics, Inc.)|Uzoq muddatli qarzning kapitalga nisbati Cara Therapeutics Inc (CARA)|Uzoq muddatli qarzning o'z kapitaliga nisbati Chromocell Therapeutics CHRO|Uzoq muddatli qarzning kapitalga koeffitsiyenti ELYM|ITCI - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Longboard Pharmaceuticals Inc|MRNS: Uzoq muddatli qarzning kapitalga nisbati|NKGen Biotech Corp (NKGN) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati NeuroBo Pharmaceuticals|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi SAGE (sagerx.com)|Uzoq muddatli qarzning kapitalga nisbati SNPX|Uzoq muddatli qarzning kapitalga nisbati Trevena Inc. (TRVN)|Vigil Neuroscience, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Anew Medical Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Cerevel Therapeutics - Uzoq muddatli qarzning kapitalga nisbati